Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894719048> ?p ?o ?g. }
- W2894719048 abstract "Abstract Increased copy number alterations (CNAs) indicative of chromosomal instability (CIN) have been associated with poor cancer outcome. Here, we study CNAs as potential biomarkers of bevacizumab (BVZ) response in metastatic colorectal cancer (mCRC). We cluster 409 mCRCs in three subclusters characterized by different degrees of CIN. Tumors belonging to intermediate-to-high instability clusters have improved outcome following chemotherapy plus BVZ versus chemotherapy alone. In contrast, low instability tumors, which amongst others consist of POLE -mutated and microsatellite-instable tumors, derive no further benefit from BVZ. This is confirmed in 81 mCRC tumors from the phase 2 MoMa study involving BVZ. CNA clusters overlap with CRC consensus molecular subtypes (CMS); CMS2/4 xenografts correspond to intermediate-to-high instability clusters and respond to FOLFOX chemotherapy plus mouse avastin (B20), while CMS1/3 xenografts match with low instability clusters and fail to respond. Overall, we identify copy number load as a novel potential predictive biomarker of BVZ combination therapy." @default.
- W2894719048 created "2018-10-12" @default.
- W2894719048 creator A5001177562 @default.
- W2894719048 creator A5003271927 @default.
- W2894719048 creator A5005112202 @default.
- W2894719048 creator A5005769424 @default.
- W2894719048 creator A5010276006 @default.
- W2894719048 creator A5010597176 @default.
- W2894719048 creator A5015297540 @default.
- W2894719048 creator A5018614325 @default.
- W2894719048 creator A5022293812 @default.
- W2894719048 creator A5022897881 @default.
- W2894719048 creator A5030055598 @default.
- W2894719048 creator A5043942519 @default.
- W2894719048 creator A5045546892 @default.
- W2894719048 creator A5048735052 @default.
- W2894719048 creator A5053061172 @default.
- W2894719048 creator A5054413273 @default.
- W2894719048 creator A5060176567 @default.
- W2894719048 creator A5061172196 @default.
- W2894719048 creator A5065342383 @default.
- W2894719048 creator A5066565774 @default.
- W2894719048 creator A5066581807 @default.
- W2894719048 creator A5067798840 @default.
- W2894719048 creator A5069169073 @default.
- W2894719048 creator A5075839502 @default.
- W2894719048 creator A5078760536 @default.
- W2894719048 creator A5079683746 @default.
- W2894719048 creator A5080144457 @default.
- W2894719048 creator A5081418446 @default.
- W2894719048 creator A5081985776 @default.
- W2894719048 creator A5083943954 @default.
- W2894719048 creator A5085952658 @default.
- W2894719048 creator A5087562649 @default.
- W2894719048 creator A5090856144 @default.
- W2894719048 date "2018-10-05" @default.
- W2894719048 modified "2023-10-06" @default.
- W2894719048 title "Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy" @default.
- W2894719048 cites W1144409159 @default.
- W2894719048 cites W1481972425 @default.
- W2894719048 cites W1544851750 @default.
- W2894719048 cites W1878663564 @default.
- W2894719048 cites W1934094702 @default.
- W2894719048 cites W1940241680 @default.
- W2894719048 cites W1984068087 @default.
- W2894719048 cites W2002246796 @default.
- W2894719048 cites W2006288875 @default.
- W2894719048 cites W2016661249 @default.
- W2894719048 cites W2020016182 @default.
- W2894719048 cites W2038143310 @default.
- W2894719048 cites W2042883111 @default.
- W2894719048 cites W2044291297 @default.
- W2894719048 cites W2046445045 @default.
- W2894719048 cites W2052228812 @default.
- W2894719048 cites W2066560754 @default.
- W2894719048 cites W2068737632 @default.
- W2894719048 cites W2084833108 @default.
- W2894719048 cites W2094599623 @default.
- W2894719048 cites W2095374934 @default.
- W2894719048 cites W2096235123 @default.
- W2894719048 cites W2103441770 @default.
- W2894719048 cites W2108234281 @default.
- W2894719048 cites W2108516575 @default.
- W2894719048 cites W2108950512 @default.
- W2894719048 cites W2109491042 @default.
- W2894719048 cites W2110725987 @default.
- W2894719048 cites W2111391096 @default.
- W2894719048 cites W2111584304 @default.
- W2894719048 cites W2113900564 @default.
- W2894719048 cites W2119180969 @default.
- W2894719048 cites W2122730895 @default.
- W2894719048 cites W2123636561 @default.
- W2894719048 cites W2127640925 @default.
- W2894719048 cites W2131705241 @default.
- W2894719048 cites W2138682295 @default.
- W2894719048 cites W2139132031 @default.
- W2894719048 cites W2143743735 @default.
- W2894719048 cites W2149681218 @default.
- W2894719048 cites W2154941270 @default.
- W2894719048 cites W2157769714 @default.
- W2894719048 cites W2157852151 @default.
- W2894719048 cites W2164837623 @default.
- W2894719048 cites W2262414037 @default.
- W2894719048 cites W2533621937 @default.
- W2894719048 cites W2569086487 @default.
- W2894719048 cites W2591743724 @default.
- W2894719048 cites W2594373254 @default.
- W2894719048 cites W2599059217 @default.
- W2894719048 cites W2605783169 @default.
- W2894719048 cites W2765339798 @default.
- W2894719048 cites W2803248983 @default.
- W2894719048 cites W4247053599 @default.
- W2894719048 cites W4320800276 @default.
- W2894719048 doi "https://doi.org/10.1038/s41467-018-06567-6" @default.
- W2894719048 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6173768" @default.
- W2894719048 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30291241" @default.
- W2894719048 hasPublicationYear "2018" @default.
- W2894719048 type Work @default.
- W2894719048 sameAs 2894719048 @default.
- W2894719048 citedByCount "50" @default.